GILD eyes on $106.82: Key resistance before Trump pharma tariffsPharma next up in Trump's cross-hairs.
GILD is waiting at a moderate resistance.
News could dump it or break and rocket.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.349 CHF
435.94 M CHF
26.09 B CHF
1.24 B
About Gilead Sciences, Inc.
Sector
Industry
CEO
Daniel P. O'Day
Website
Headquarters
Foster City
Founded
1987
FIGI
BBG006TLQ7X8
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
GILD is a dangerous buy, but a buy nonetheless for me.There is a lot NOT to like about this trade. Yes, I see how far it has run. Yes, I see how fast it is falling. Yes, I see the gap from 96 to 102 that “must” be filled. Yes, the market overall has been unhelpful of late. I realize all of it and I wouldn’t necessarily recommend anyone follow me
GILD - looks ready for a pull back. Some nice targets on GILD let's see how many we can get to. What do you think? Will break through stops and continue higher or flush? GL!
Gilead Sciences (GILD) Soars 4.93% on Strong Q4 Earnings ReportsGilead Sciences (NASDAQ: NASDAQ:GILD ) is making waves in the biotech sector after delivering a stellar fourth-quarter earnings report that not only crushed Wall Street expectations but also set the stage for a promising 2025. The stock surged 4.50% in premarket trading on Wednesday, signaling stro
Harmonic Within a Harmonic on Gilead. GILDThey are crooked looking, but are present. Another tangent of evidence on the obvious fractal nature of markets. That thick candle to us confirms break of trend and the underlying indicators are also suggestive. It is prudent to note that the indicator readings have been formed by price action, volu
$GILD Gilead Sciences Inc - Fib GP On Alert NASDAQ:GILD Gilead Sciences Inc -
-The ATH Fib Golden Pocket on alert for next week.
-Potential earnings Run-up
-Rotation
GILD Gilead Sciences Options Ahead of EarningsAnalyzing the options chain and the chart patterns of GILD Gilead Sciences prior to the earnings report this week,
I would consider purchasing the 89usd strike price Calls with
an expiration date of 2024-11-15,
for a premium of approximately $2.91.
If these options prove to be profitable prior to th
Gilead Pullback!Three bear bars is a concern but, with 2 different measured moves objects above and a solid trend upwards, I think its worth a shot for a long. If it is worth anything, the whole industry seems to be trending positively.
Gilead Sciences (GILD): Will Support Hold or Will We See a Drop?We've neglected Gilead Sciences for a while, but it's time for an update. Unfortunately, our entry looking back wasn't ideal, as the stock has fallen below the 61.8% retracement level. It found support just below the 78.6% level, which marks the bottom of our range. This level was precisely touched,
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
GILD5050849
Gilead Sciences, Inc. 2.8% 01-OCT-2050Yield to maturity
7.20%
Maturity date
Oct 1, 2050
US375558BS1
GILEAD SCIEN 20/40Yield to maturity
6.71%
Maturity date
Oct 1, 2040
US375558BK8
GILEAD SCIENCES 16/47Yield to maturity
6.51%
Maturity date
Mar 1, 2047
GILD4184058
Gilead Sciences, Inc. 4.5% 01-FEB-2045Yield to maturity
6.26%
Maturity date
Feb 1, 2045
GISE
GILEAD SCIENCES 2046Yield to maturity
6.25%
Maturity date
Mar 1, 2046
GILD4104362
Gilead Sciences, Inc. 4.8% 01-APR-2044Yield to maturity
6.16%
Maturity date
Apr 1, 2044
GILD5939386
Gilead Sciences, Inc. 5.6% 15-NOV-2064Yield to maturity
6.02%
Maturity date
Nov 15, 2064
GILD5939385
Gilead Sciences, Inc. 5.5% 15-NOV-2054Yield to maturity
5.91%
Maturity date
Nov 15, 2054
GILD5648609
Gilead Sciences, Inc. 5.55% 15-OCT-2053Yield to maturity
5.91%
Maturity date
Oct 15, 2053
GILD.GO
Gilead Sciences, Inc. 5.65% 01-DEC-2041Yield to maturity
5.82%
Maturity date
Dec 1, 2041
GISG
GILEAD SCIENCES 16/36Yield to maturity
5.72%
Maturity date
Sep 1, 2036
See all GIS bonds
Curated watchlists where GIS is featured.
Related stocks
Frequently Asked Questions
The current price of GIS is 87.190 CHF — it has decreased by −9.84% in the past 24 hours. Watch GILEAD SCIENCES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange GILEAD SCIENCES stocks are traded under the ticker GIS.
GIS stock has fallen by −9.84% compared to the previous week, the month change is a −16.21% fall, over the last year GILEAD SCIENCES has showed a 33.49% increase.
We've gathered analysts' opinions on GILEAD SCIENCES future price: according to them, GIS price has a max estimate of 114.17 CHF and a min estimate of 72.58 CHF. Watch GIS chart and read a more detailed GILEAD SCIENCES stock forecast: see what analysts think of GILEAD SCIENCES and suggest that you do with its stocks.
GIS stock is 11.48% volatile and has beta coefficient of 0.37. Track GILEAD SCIENCES stock price on the chart and check out the list of the most volatile stocks — is GILEAD SCIENCES there?
Today GILEAD SCIENCES has the market capitalization of 109.50 B, it has decreased by −6.87% over the last week.
Yes, you can track GILEAD SCIENCES financials in yearly and quarterly reports right on TradingView.
GILEAD SCIENCES is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
GIS earnings for the last quarter are 1.73 CHF per share, whereas the estimation was 1.58 CHF resulting in a 9.35% surprise. The estimated earnings for the next quarter are 1.56 CHF per share. See more details about GILEAD SCIENCES earnings.
GILEAD SCIENCES revenue for the last quarter amounts to 6.87 B CHF, despite the estimated figure of 6.50 B CHF. In the next quarter, revenue is expected to reach 6.01 B CHF.
GIS net income for the last quarter is 1.62 B CHF, while the quarter before that showed 1.06 B CHF of net income which accounts for 52.50% change. Track more GILEAD SCIENCES financial stats to get the full picture.
Yes, GIS dividends are paid quarterly. The last dividend per share was 0.70 CHF. As of today, Dividend Yield (TTM)% is 2.91%. Tracking GILEAD SCIENCES dividends might help you take more informed decisions.
GILEAD SCIENCES dividend yield was 3.33% in 2024, and payout ratio reached 805.23%. The year before the numbers were 3.70% and 66.62% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 16, 2025, the company has 17.6 K employees. See our rating of the largest employees — is GILEAD SCIENCES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GILEAD SCIENCES EBITDA is 12.20 B CHF, and current EBITDA margin is 46.74%. See more stats in GILEAD SCIENCES financial statements.
Like other stocks, GIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GILEAD SCIENCES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GILEAD SCIENCES technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GILEAD SCIENCES stock shows the buy signal. See more of GILEAD SCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.